UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000011162
Receipt No. R000013074
Official scientific title of the study Measurement of cerebrovascular reserve using 3D-ASL MRI
Date of disclosure of the study information 2013/07/10
Last modified on 2017/01/11 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Measurement of cerebrovascular reserve using 3D-ASL MRI
Title of the study (Brief title) Measurement of cerebrovascular reserve using 3D-ASL MRI
Region
Japan

Condition
Condition Obstructive cerebrovascular disease
Classification by specialty
Neurology Neurosurgery
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To establish the method for measurement of cerebrovascular reserve using 3D-ASL MRI
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes To optimize imaging parameters
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Medicine
Interventions/Control_1 Intravenous infusion of acetazolamide 1000 mg
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Healthy adult
Person without neuropsychiatric disorder
Person without chronic disease
Key exclusion criteria Pregnant woman, possible of pregnancy
Contraindications for an MRI scan
Contraindications for acetazolamide
Target sample size 8

Research contact person
Name of lead principal investigator Toshimasa Hara
Organization Kitasato University, School of Medicine
Division name Department of Diagnostic Radiology
Address 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0375, Japan
TEL
Email

Public contact
Name of contact person Toshimasa Hara
Organization Kitasato University, School of Medicine
Division name Department of Diagnostic Radiology
Address 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0375, Japan
TEL
Homepage URL
Email

Sponsor
Institute Kitasato University, School of Medicine
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 07 Month 10 Day

Progress
Recruitment status Completed
Date of protocol fixation
2012 Year 01 Month 18 Day
Anticipated trial start date
2012 Year 02 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results http://www.ajnr.org/content/35/6/1111.full
Results
Other related information

Management information
Registered date
2013 Year 07 Month 10 Day
Last modified on
2017 Year 01 Month 11 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000013074